Law No. 48/2024/QH15 on VAT, passed by the National Assembly on November 26, 2024, is the new governing law for... Read more
Category: Uncategorized
Regulatory Update: Decision No. 3563/QĐ-BTC on New Global Minimum Tax (GMT) Administrative Procedures
Decision No. 3563/QĐ-BTC, issued by the Ministry of Finance on October 21, 2025, announces 04 new administrative procedures within the... Read more
Regulatory Update: Decree No. 236/2025/ND-CP on Detailed Regulations for Implementing Global Minimum Tax
Decree No. 236/2025/NĐ-CP, issued by the Government on August 29, 2025, details the implementation of the Global Minimum Tax (GMT)... Read more
Regulatory Update: Circular No. 39/2025/TT-BYT on Delegating Authority for Pharmaceutical Tasks and Administrative Procedures
Circular No. 39/2025/TT-BYT, issued by the Ministry of Health (MoH) on September 20, 2025, details the delegation of certain duties... Read more
Regulatory Update: Decree No. 163/2025/ND-CP on Detailed Regulations and Measures for Implementing the Law on Pharmacy
This decree, issued by the Government of Vietnam on June 29, 2025, provides updated regulations on pharmaceutical activities, detailing several... Read more
Strategic Collaboration Signed to Advance Metabolic Disorder Treatments
Zealand Pharma A/S and OTR Therapeutics have announced a strategic collaboration and license agreement focused on the discovery and development... Read more
China’s NMPA Clears Two Sanofi Treatments for Rare Hematologic Diseases
China’s National Medical Products Administration (NMPA) has granted approvals for two of Sanofi's rare hematologic disease treatments: Qfitlia (fitusiran) and... Read more
European Union Advances New Pharmaceutical Regulatory Framework
Negotiators from the European Parliament (EP) and the EU Council have reached a provisional agreement on a new regulatory framework... Read more
Novel Monoclonal Antibody Gains FDA Clearance for Generalized Myasthenia Gravis
The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Amgen's monoclonal antibody, Uplizna (inebilizumab). The new... Read more









